LOGIN  |  REGISTER
Amneal Pharmaceuticals

Ardent Health to Participate in September Investor Conferences

August 25, 2025 | Last Trade: US$8.78 0.28 -3.09

BRENTWOOD, Tenn. / Aug 25, 2025 / Business Wire / Ardent Health (NYSE: ARDT), a leading provider of healthcare in growing mid-sized urban communities across the U.S., today announced that members of the Company’s management team will participate in the following upcoming investor conferences:

  • Wells Fargo Healthcare Conference on Thursday, September 4, 2025, in Boston, Massachusetts. Members of the management team will participate in a fireside chat at 8:45 a.m. ET that same day.
  • Morgan Stanley 23rd Annual Global Healthcare Conference on Monday, September 8, 2025, in New York City, New York. Members of the management team will participate in a fireside chat at 7:45 a.m. ET that same day.
  • Jefferies 2025 Healthcare Services Conference on Monday, September 29, 2025, in Nashville, Tennessee. Members of the management team will participate in a fireside chat at 10:45 a.m. ET that same day.

A live audio webcast of these presentations will be available in the Investor Relations section of the Company’s website, at https://ir.ardenthealth.com. A replay will be available on the same webpage after the webcast conclusion.

In conjunction with these conferences, the Ardent Health management team will be available to participate in one-on-one meetings with investors registered to attend each conference. For more information, please contact your sales representative at the host firm, or Dave Styblo, Ardent Health’s senior vice president of investor relations, at This email address is being protected from spambots. You need JavaScript enabled to view it..

About Ardent Health

Ardent Health (NYSE: ARDT) is a leading provider of healthcare in growing mid-sized urban communities across the U.S. With a focus on people and investments in innovative services and technologies, Ardent is passionate about making healthcare better and easier to access. Through its subsidiaries, the Company delivers care through a system of 30 acute care hospitals and approximately 280 sites of care with over 1,800 employed and affiliated providers across six states. For more information, please visit ardenthealth.com.

Recursion

Stock Quote

Featured Stock

Cue Biopharma

Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...

CLICK TO LEARN MORE

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page